Aripiprazole use in children and adolescents: A case series [Çocuk ve gençlerde aripiprazol kullanimi: Olgu serisi]
| dc.contributor.author | Bildik T. | |
| dc.contributor.author | Özbaran N.B. | |
| dc.contributor.author | Küçükköse M. | |
| dc.contributor.author | Ardiç Ü.A. | |
| dc.date.accessioned | 2019-10-26T22:30:32Z | |
| dc.date.available | 2019-10-26T22:30:32Z | |
| dc.date.issued | 2010 | |
| dc.department | Ege Üniversitesi | en_US |
| dc.description.abstract | In children and adolescents, atypical antipsychotics have been largely used to treat aggression, mood instability, and psychosis. There is a growing interest in the use of aripiprazole in children and adolescents with schizophrenia, pervasive developmental disorders, and bipolar disorders. A series of 7 children and adolescents (ages 11-17 years, 5 males) were treated with aripiprazole for different psychiatric disorders. All patients had been treated previously with several psychotropic drugs. Aripiprazole was initiated at a starting dose of 2.5 or 5 mg daily and optimal dosages ranged from 5 to 10 mg daily. Six of the 7 patients appeared to benefit from aripiprazole. Neither extrapyramidal side effects nor agitation was observed in any case. Aripiprazole was well tolerated and effective in our cases and appears to be a safe and efficacious alternative in the child and adolescents. However, prospective clinical trials with a randomized placebo controlled design are needed. | en_US |
| dc.identifier.endpage | 93 | en_US |
| dc.identifier.issn | 1017-7833 | |
| dc.identifier.issn | 1017-7833 | en_US |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.scopusquality | N/A | en_US |
| dc.identifier.startpage | 84 | en_US |
| dc.identifier.uri | https://hdl.handle.net/11454/19699 | |
| dc.identifier.volume | 20 | en_US |
| dc.indekslendigikaynak | Scopus | en_US |
| dc.language.iso | tr | en_US |
| dc.relation.ispartof | Klinik Psikofarmakoloji Bulteni | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Aripiprazole | en_US |
| dc.subject | Early onset schizophrenia | en_US |
| dc.subject | Major depression | en_US |
| dc.subject | Mental retardation | en_US |
| dc.subject | Mood disorder | en_US |
| dc.subject | Obsessive-compulsive disorder | en_US |
| dc.title | Aripiprazole use in children and adolescents: A case series [Çocuk ve gençlerde aripiprazol kullanimi: Olgu serisi] | en_US |
| dc.type | Article | en_US |
